Governor Moore Tours AstraZeneca in Gaithersburg, Joins BioHub Maryland to Announce New Biopharmaceutical Workforce Development Partnership

Published: 11/2/2023

ANNAPOLIS, MD — Governor Wes Moore today toured the AstraZeneca site in Gaithersburg and joined BioHub Maryland to announce a new skills training agreement with the Dublin, Ireland-based National Institute of Bioprocessing Research and Training, a global leader in biopharmaceutical manufacturing training and research. The partnership makes BioHub Maryland the exclusive training partner in the National Capital Region, enabling Marylanders—including veterans and members of disadvantaged communities—to learn a unique brand of skills required to work in the life sciences industry. 

“Today, we’re not just here to celebrate this new BioHub partnership. We’re here to celebrate a new direction for Maryland’s economy and workforce,” said Gov. Moore. “We are ready to win. We are ready to grow and we are ready to show the entire country what we’re made of.”

Governor Moore stands with staffers at AstraZeneca Gaithersburg. 

AstraZeneca is a global science-led, patient-focused pharmaceutical company. It is Montgomery County’s seventh largest employer, with more than 3,500 workers, and is Frederick County’s eighth largest employer, with 700 workers. BioHub Maryland is a Maryland Tech Council initiative, accelerating the life sciences industry for companies and career seekers to expand the state’s global innovation advantage.

Governor Moore visits a lab at AstraZeneca Gaithersburg 

The state of Maryland, through the Department of Commerce, has invested $2.75 million in the BioHub Workforce initiative. The investment underscores the importance of life sciences to Maryland’s economic future as a sector that will continue to create good jobs for Marylanders.